- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04838691
Premenstrual Syndrome and Interpersonal Counseling
April 8, 2021 updated by: Zeynep Seyyide Bozkurt, Istanbul University-Cerrahpasa
The Effect of Interpersonal Counseling in Symptoms Management of Premenstrual Syndrome
This study aims to test the effectiveness of interpersonal counseling in PMS symptom management in university students experiencing PMS symptoms.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
People diagnosed with Premestrual Syndrome were identified through an online questionnaire.
80 people who were identified and accepted to study were divided into two groups as experiment and control.
Initially, pre-menstrual screening tool, interpersonal relationship dimensions scale and perceived stress scale were applied to all groups.
Then, 8 sessions of interpersonal counseling, each lasting 40 minutes, were applied to the experimental group for 2 months.
Scales were repeated for both groups after the application was completed.
Repeated measurements were made 3 months later.
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- Istanbul University-Cerrahpasa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 30 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- According to the Pre-menstrual Symptom Screening Instrument, which is located in the group living with AES (Pre-Mental Syndrome)
- between the ages of 18-30
- Menstruating at regular intervals for at least 2 years (21-35 days)
- Those who have never given birth
- Speak and understand Turkish
- It will consist of people who have not received antidepressant, oral contraceptive or hormone therapy for any reason.
Exclusion Criteria:
- Having a known gynecological disease (endometriosis, polycystic ovary, ...)
- A known, ongoing physical health problem (diabetes, rheumatic disease, ...)
- Any psychiatric disease diagnosed (psychotic disorder, mood disorder, anxiety disorder ...)
- People who use cigarettes, alcohol or substances
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: interpersonal relations counseling applied
8 sessions of interpersonal relations counseling, each lasting 40 minutes, were applied for 2.
|
In the intervention group, it will be administered for 40 minutes for 8 weeks to people with symptoms of premenstrual syndrome.
|
No Intervention: no application
No action taken.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Premenstrual Symptom Screening Tool
Time Frame: Baseline (beginning), Change from Baseline PMDD or PMS after 2 months, Change from Baseline PMDD or PMS after 5 months,
|
Women will be divided into 3 different groups as a result of the points they get from PSST.
The first group will consist of women who fully meet the PMDD criteria.
These Women must have at least one of the four main symptom groups from the group A symptoms plus any of the 4 symptoms marked as moderate to severe on the instrument.
In addition, he should have reported that at least one of the questions in group B was severe, and yes answers should be given to both questions in group C.The second group is the group that meets the PMS living criteria.
These women are expected to have marked at least one of the 4 main symptoms as moderate to severe from the group A questions and any other 4 symptoms as moderate to severe to answer the group B questions as moderate to severe, and to answer yes to at least one question from the C group.The third group will be considered as the group with subthreshold symptoms consisting of those who do not meet the criteria for entering the other two groups.
|
Baseline (beginning), Change from Baseline PMDD or PMS after 2 months, Change from Baseline PMDD or PMS after 5 months,
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Scale Of Interpersonal Relatıonshıps Dımensıons
Time Frame: Baseline (beginning), Change from Baseline Sub-dimensions of Interpersonal Relationships Scale after 2 months, Change from Baseline Sub-dimensions of Interpersonal Relationships Scale after 5 months
|
The scale, which consists of 53 items in total, has 4 sub-dimensions. These are Confirmation, addiction, empathy, trust in others, and emotional awareness. The high score obtained from each sub-dimension of the scale indicates that the individual has more features evaluated by the relevant sub-dimension. |
Baseline (beginning), Change from Baseline Sub-dimensions of Interpersonal Relationships Scale after 2 months, Change from Baseline Sub-dimensions of Interpersonal Relationships Scale after 5 months
|
Perceived stress scale
Time Frame: Baseline (beginning), 2 months after beginning, 3 months after beginning
|
The higher the total score, the more negative it is.
|
Baseline (beginning), 2 months after beginning, 3 months after beginning
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Neslihan Özcan, Professor, Istanbul University-Cerrahpasa
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 6, 2020
Primary Completion (Actual)
May 6, 2020
Study Completion (Actual)
August 30, 2020
Study Registration Dates
First Submitted
April 3, 2021
First Submitted That Met QC Criteria
April 8, 2021
First Posted (Actual)
April 9, 2021
Study Record Updates
Last Update Posted (Actual)
April 9, 2021
Last Update Submitted That Met QC Criteria
April 8, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Zeynep
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
Sharing is considered inappropriate before the end of the study.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premenstrual Syndrome
-
Esra ÖZERKTO Karatay UniversityRecruitingPremenstrual Syndrome-PMSTurkey
-
Shaare Zedek Medical CenterUnknownPremenstrual Syndrome-PMS
-
Philipps University Marburg Medical CenterLinkoeping UniversityCompletedPremenstrual Syndrome (PMS)Germany
-
Cairo UniversityNot yet recruitingPremenstrual Tension
-
Cairo UniversityNot yet recruitingPremenstrual Pain
-
Terra Biological LLCCompletedPremenstrual Syndrome (PMS)
-
Massachusetts General HospitalWithdrawnPremenstrual Dysphoric Disorder | Premenstrual Syndrome | Premenstrual Tension | Menstrual Related Mood DisorderUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownDepression | Premenstrual Dysphoric Disorder (PMDD)Israel
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedPremenstrual SyndromeUnited States
Clinical Trials on interpersonal counseling
-
Hospital District of Helsinki and UusimaaFinnish Institute for Health and Welfare; City of Espoo; Ministry of Social Affairs...UnknownDepressive DisorderFinland
-
University of ArizonaNational Cancer Institute (NCI)Completed
-
Children's Hospital of PhiladelphiaNational Institute of Mental Health (NIMH); Rutgers UniversityCompleted
-
Inter-American Development BankFundación Saldarriaga Concha; Instituto Departamental de Salud de Nariño; Ministerio...UnknownChild Obesity | Malnutrition, Child | Exclusive Breast Feeding
-
Johns Hopkins UniversityUniversity of Toronto; Amherst CollegeCompleted
-
New York State Psychiatric InstituteNational Institute of Allergy and Infectious Diseases (NIAID); Columbia University and other collaboratorsRecruitingEffectiveness and Cost-Effectiveness of Depression Treatment for Individuals With TB in South AfricaDepression | TuberculosisSouth Africa
-
Kadriye DemirCompletedPerr Bulling, Middle School Child, School Nursing, Peplau-Interpersonel Relationship TheoryTurkey
-
University of RochesterNational Institute of Mental Health (NIMH)Completed
-
University of ArizonaNational Cancer Institute (NCI)Completed
-
University of ArizonaAmerican Cancer Society, Inc.RecruitingCancer | Psychological Distress | Informal Caregivers | Cancer SurvivorsUnited States